Morgan Stanley’s Core Scientific Inc Tranche 2 Warrants CORZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.3K Buy
1,857
+1,729
+1,351% +$40.7K ﹤0.01% 6541
2026
Q1
$1.92K Sell
128
-105
-45% -$1.79K ﹤0.01% 7339
2025
Q4
$3.39K Sell
233
-4,795
-95% -$83.7K ﹤0.01% 7138
2025
Q3
$90.2K Sell
5,028
-13,186
-72% -$193K ﹤0.01% 6200
2025
Q2
$313K Sell
18,214
-31,465
-63% -$313K ﹤0.01% 5667
2025
Q1
$357K Hold
49,679
﹤0.01% 5483
2024
Q4
$696K Hold
49,679
﹤0.01% 5279
2024
Q3
$584K Hold
49,679
﹤0.01% 5327
2024
Q2
$432K Buy
49,679
+43,395
+691% +$166K ﹤0.01% 5358
2024
Q1
$15.1K Buy
+6,284
New +$15.5K ﹤0.01% 6569

Other funds holding CORZZ

Morgan Stanley's CORZZ Position: Q2 2026 in Review

Morgan Stanley increased its Core Scientific Inc Tranche 2 Warrants (CORZZ) stake by 1,351% in Q2 2026, buying an estimated $40.7K and bringing the position to 1,857 shares worth $46.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6541.

Morgan Stanley first reported a position in CORZZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $696K in Q4 2024. 30 funds tracked by Wall St. Rank hold CORZZ as of Q2 2026.

  • Morgan Stanley held 1,857 shares of Core Scientific Inc Tranche 2 Warrants worth $46.3K as of Q2 2026.
  • Morgan Stanley bought 1,729 Core Scientific Inc Tranche 2 Warrants shares in Q2 2026, an estimated $40.7K.
  • Core Scientific Inc Tranche 2 Warrants made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6541 holding.
  • Morgan Stanley first reported a position in Core Scientific Inc Tranche 2 Warrants in Q1 2024 and has held it in 10 quarters since.
  • Morgan Stanley's Core Scientific Inc Tranche 2 Warrants position peaked at $696K in Q4 2024.
  • 30 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 2 Warrants as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.